SCHEMBL10092552

SCHEMBL10092552

CCc1ccc(NC(C)=S)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.58
NPC1 O15118 5/20 0.58
SRC P12931 1/20 0.56
SMN1; SMN2 Q16637 4/20 0.56
TAS2R38 P59533 1/20 0.56
POLB P06746 2/20 0.54
MAPT P10636 4/20 0.53
ALDH1A1 P00352 3/20 0.53
HPGD P15428 2/20 0.50
GRIN2D O15399 1/20 0.50
GRIN3B O60391 1/20 0.50
GRIN1 Q05586 1/20 0.50
GRIN2A Q12879 1/20 0.50
GRIN2B Q13224 1/20 0.50
GRIN2C Q14957 1/20 0.50
GRIN3A Q8TCU5 1/20 0.50
SIGMAR1 Q99720 1/20 0.50
HDAC3 O15379 1/20 0.47
HDAC4 P56524 1/20 0.47
HDAC1 Q13547 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2300811 0.85 GRIN2D (0.58) RAB9ANPC1SRCSMN1; SMN2TAS2R38
SCHEMBL9453953 0.84 RAB9A (0.66) RAB9ANPC1SRCSMN1; SMN2POLB
SCHEMBL24777641 0.84 RAB9A (0.60) RAB9ANPC1SMN1; SMN2POLBMAPT
SCHEMBL14511451 0.83 TAS2R38 (0.75) SMN1; SMN2TAS2R38POLBMAPTALDH1A1
SCHEMBL18735412 0.83 RAB9A (0.59) RAB9ANPC1SRCSMN1; SMN2POLB
SCHEMBL17191531 0.81 TAS2R38 (0.54) RAB9ANPC1SRCSMN1; SMN2TAS2R38
SCHEMBL24778059 0.80 RAB9A (0.56) RAB9ANPC1SMN1; SMN2POLBMAPT
SCHEMBL17469336 0.79 ALDH1A1 (0.64) RAB9ANPC1SMN1; SMN2POLBMAPT
SCHEMBL8103753 0.79 RAB9A (0.54) RAB9ANPC1SRCSMN1; SMN2POLB
SCHEMBL26033861 0.79 RAB9A (0.54) RAB9ANPC1SRCSMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170312363-A1 MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2017-11-02 US disclosed
US-9386938-B2 Methods for collagen imaging Collagen Medical, LLC (US) 2016-07-12 US disclosed
US-20120114557-A1 Methods for Collagen Imaging Collagen Medical, LLC (US) 2012-05-10 US disclosed
US-8034898-B2 Methods of collagen imaging Collagen Medical, LLC (US) 2011-10-11 US disclosed
US-7572459-B2 Prevention infections in humans, animals STARPHARMA PTY LTD. (AU) 2009-08-11 US disclosed
US-20080058636-A1 METHODS OF MYOCARDIAL IMAGING EPIX PHARMACEUTICALS, INC. 2008-03-06 US disclosed
US-20080044360-A1 METHODS OF COLLAGEN IMAGING EPIX PHARMACEUTICALS, INC. 2008-02-21 US disclosed
US-20070293656-A1 COLLAGEN BINDING PEPTIDES EPIX PHARMACEUTICALS, INC. 2007-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120114557-A1 Methods for Collagen Imaging COL14A1, COL2A1, COL1A1 RAB9A 3381/4885NPC1 1722/4885SRC 3429/4885
US-20080058636-A1 METHODS OF MYOCARDIAL IMAGING FABP3, TNNI3, TNNT2 RAB9A 3536/4885NPC1 2556/4885SRC 3859/4885
US-20080044360-A1 METHODS OF COLLAGEN IMAGING COL14A1, COL2A1, COL1A1 RAB9A 3387/4885NPC1 1806/4885SRC 3416/4885
US-20070293656-A1 COLLAGEN BINDING PEPTIDES COL14A1, COL2A1, COL1A1 RAB9A 2721/4885NPC1 3980/4885SRC 3096/4885
US-20170312363-A1 MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR HDGF, F11, F12 RAB9A 3753/4885NPC1 2429/4885SRC 4737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.